Ortho Dermatologics to Present New Data at the 2021 American Academy of Dermatology Annual Meeting
News provided by
Share this article
®, DUOBRII
®
LAVAL, Quebec, April 21, 2021 /PRNewswire/ Bausch Health Companies Inc. (NYSE/TSX: BHC) ( Bausch Health ) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the presentation of six posters during the virtual American Academy of Dermatology (AAD) Annual Meeting, which takes place April 23-25, 2021.
One presentation will feature new analyses of ARAZLO
® (tazarotene) Lotion, 0.045%, including new topline efficacy results from a post hoc analysis of two Phase 3 studies on participants with moderate-to-severe acne. Approved for patients nine years of age and older, ARAZLO has been commercially available since 2020. Two other presentations will highlight DUOBRII